|
PF-36930 |
ALLIAMPICIN-SB 1.5 g Polvo para Uso Parenteral |
2011-02-03 |
|
Ranbaxy Laboratories Limited |
India
|
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-36953 |
ASTAZONE 1000 mg Polvo para Uso Parenteral |
2011-02-09 |
|
Ranbaxy Laboratories Limited |
India
|
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-36967 |
CEFAST 1 g Polvo para Solución Inyectable |
2011-02-10 |
|
Ranbaxy Laboratories Limited |
India
|
Amicelco |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-42842 |
TAZOPAR 4.50 g polvo para solucion inyectable |
2014-04-23 |
|
Lupin Limited |
India
|
Droguería Y Farmacia Lanquetin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41065 |
NEXIUM 20 mg Tabletas recubiertas |
2028-01-12 |
|
Astrazeneca, S.A. de C.V. |
Mexico
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39041 |
LOSEC 40 mg Polvo para Infusión IV |
2012-06-29 |
|
Astrazeneca Uk Limited |
Reino Unido
|
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-31240 |
ATACAND PLUS 16/12.5 mg comprimidos |
2013-08-26 |
|
Astrazeneca Uk Limited |
Reino Unido
|
Colon S.A. |
Agencias J.i. Cohen |
Refasa S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-20595 |
ATACAND 8 mg tabletas |
2013-11-05 |
|
Astrazeneca Uk Limited |
Reino Unido
|
Agencias J.I. Cohen |
Droguería Colón |
Refasa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55319 |
BRILINTA 60 mg Comprimidos recubiertos |
2023-06-04 |
|
Astrazeneca AB |
Suecia
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55554 |
TAGRISSO 40 mg Comprimidos recubiertos con película |
2023-07-30 |
|
Astrazeneca AB |
Suecia
|
J.I.Cohen, S.A. |
Agencias J. I. Cohen |
Centro Distribuidor, Sociedad Anónima |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|